301 related articles for article (PubMed ID: 29392508)
21. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience.
Yang AD; Melstrom LG; Bentrem DJ; Ujiki MB; Wayne JD; Strouch M; Bell RH; Rao SM; Talamonti MS
Surgery; 2007 Oct; 142(4):529-34; discussion 534-7. PubMed ID: 17950345
[TBL] [Abstract][Full Text] [Related]
22. Main-duct intraductal papillary mucinous adenoma of the pancreas.
Takuma K; Kamisawa T; Tabata T; Kurata M; Honda G; Horiguchi S
World J Surg Oncol; 2011 Nov; 9():153. PubMed ID: 22112163
[TBL] [Abstract][Full Text] [Related]
23. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance.
Kang MJ; Jang JY; Lee KB; Chang YR; Kwon W; Kim SW
Ann Surg; 2014 Aug; 260(2):356-63. PubMed ID: 24378847
[TBL] [Abstract][Full Text] [Related]
24. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
[TBL] [Abstract][Full Text] [Related]
25. The distance of tumor spread in the main pancreatic duct of an intraductal papillary-mucinous neoplasm: where to resect and how to predict it.
Okada K; Imaizumi T; Hirabayashi K; Matsuyama M; Yazawa N; Dowaki S; Tobita K; Ohtani Y; Kawaguchi Y; Tanaka M; Inokuchi S; Makuuchi H
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):516-22. PubMed ID: 20714841
[TBL] [Abstract][Full Text] [Related]
26. [Resection of main duct and mixed type IPMN ≥5 mm].
Ceyhan GO; Scheufele F; Friess H
Chirurg; 2017 Nov; 88(11):913-917. PubMed ID: 28842734
[TBL] [Abstract][Full Text] [Related]
27. Can contrast-enhanced harmonic endoscopic ultrasonography accurately diagnose main pancreatic duct involvement in intraductal papillary mucinous neoplasms?
Ohno E; Kawashima H; Ishikawa T; Iida T; Suzuki H; Uetsuki K; Yashika J; Yamada K; Yoshikawa M; Gibo N; Aoki T; Kataoka K; Mori H; Hirooka Y; Fujishiro M
Pancreatology; 2020 Jul; 20(5):887-894. PubMed ID: 32651080
[TBL] [Abstract][Full Text] [Related]
28. Intraductal papillary-mucinous tumors of the pancreas: predictive criteria of malignancy according to pathological examination of 53 cases.
Bernard P; Scoazec JY; Joubert M; Kahn X; Le Borgne J; Berger F; Partensky C
Arch Surg; 2002 Nov; 137(11):1274-8. PubMed ID: 12413317
[TBL] [Abstract][Full Text] [Related]
29. Should all branch-duct intraductal papillary mucinous neoplasms be resected?
Plichta JK; Ban K; Fridirici Z; Godambe AS; Yong S; Pappas S; Abood GJ; Aranha GV
Am J Surg; 2015 Mar; 209(3):478-82. PubMed ID: 25605032
[TBL] [Abstract][Full Text] [Related]
30. [Surgical management of intraductal papillary mucinous neoplasms].
Jang JY
Korean J Gastroenterol; 2008 Oct; 52(4):220-5. PubMed ID: 19077523
[TBL] [Abstract][Full Text] [Related]
31. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
[TBL] [Abstract][Full Text] [Related]
32. Intraductal papillary mucinous neoplasm--when to resect?
Waters JA; Schmidt CM
Adv Surg; 2008; 42():87-108. PubMed ID: 18953811
[TBL] [Abstract][Full Text] [Related]
33. Recurrences after surgical resection of intraductal papillary mucinous neoplasm of the pancreas: a single-center study of recurrence predictive factors.
Passot G; Lebeau R; Hervieu V; Ponchon T; Pilleul F; Adham M
Pancreas; 2012 Jan; 41(1):137-41. PubMed ID: 22076564
[TBL] [Abstract][Full Text] [Related]
34. Potential predictors of disease progression for main-duct intraductal papillary mucinous neoplasms of the pancreas.
Ogura T; Masuda D; Kurisu Y; Edogawa S; Imoto A; Hayashi M; Uchiyama K; Higuchi K
J Gastroenterol Hepatol; 2013 Nov; 28(11):1782-6. PubMed ID: 23800049
[TBL] [Abstract][Full Text] [Related]
35. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
36. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
[TBL] [Abstract][Full Text] [Related]
37. IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection.
Marchegiani G; Mino-Kenudson M; Sahora K; Morales-Oyarvide V; Thayer S; Ferrone C; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Ann Surg; 2015 May; 261(5):976-83. PubMed ID: 24979607
[TBL] [Abstract][Full Text] [Related]
38. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
[TBL] [Abstract][Full Text] [Related]
39. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
Watanabe Y; Endo S; Nishihara K; Ueda K; Mine M; Tamiya S; Nakano T; Tanaka M
Surg Today; 2018 Nov; 48(11):1011-1019. PubMed ID: 29961172
[TBL] [Abstract][Full Text] [Related]
40. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
